These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 23792117)
1. A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging. Bastiat G; Pritz CO; Roider C; Fouchet F; Lignières E; Jesacher A; Glueckert R; Ritsch-Marte M; Schrott-Fischer A; Saulnier P; Benoit JP J Control Release; 2013 Sep; 170(3):334-42. PubMed ID: 23792117 [TBL] [Abstract][Full Text] [Related]
2. Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules. Simonsson C; Bastiat G; Pitorre M; Klymchenko AS; Béjaud J; Mély Y; Benoit JP Eur J Pharm Biopharm; 2016 Jan; 98():47-56. PubMed ID: 26522878 [TBL] [Abstract][Full Text] [Related]
3. Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring. Lainé AL; Gravier J; Henry M; Sancey L; Béjaud J; Pancani E; Wiber M; Texier I; Coll JL; Benoit JP; Passirani C J Control Release; 2014 Aug; 188():1-8. PubMed ID: 24878182 [TBL] [Abstract][Full Text] [Related]
4. Release, transfer and partition of fluorescent dyes from polymeric nanocarriers to serum proteins monitored by asymmetric flow field-flow fractionation. de Oliveira MA; Pound-Lana G; Capelari-Oliveira P; Pontífice TG; Silva SED; Machado MGC; Postacchini BB; Mosqueira VCF J Chromatogr A; 2021 Mar; 1641():461959. PubMed ID: 33611111 [TBL] [Abstract][Full Text] [Related]
5. Design of dye and superparamagnetic iron oxide nanoparticle loaded lipid nanocapsules with dual detectability in vitro and in vivo. Bohley MS; Birch E; Baumann FJ; Dillinger AE; Tamm ER; Goepferich AM Int J Pharm; 2020 Jul; 585():119433. PubMed ID: 32447023 [TBL] [Abstract][Full Text] [Related]
6. Enhanced and preferential internalization of lipid nanocapsules into human glioblastoma cells: effect of a surface-functionalizing NFL peptide. Karim R; Lepeltier E; Esnault L; Pigeon P; Lemaire L; Lépinoux-Chambaud C; Clere N; Jaouen G; Eyer J; Piel G; Passirani C Nanoscale; 2018 Jul; 10(28):13485-13501. PubMed ID: 29972178 [TBL] [Abstract][Full Text] [Related]
7. Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia. Briot T; Roger E; Lautram N; Verger A; Clavreul A; Lagarce F Int J Nanomedicine; 2017; 12():8427-8442. PubMed ID: 29200853 [TBL] [Abstract][Full Text] [Related]
8. Light-triggered release from dye-loaded fluorescent lipid nanocarriers in vitro and in vivo. Bouchaala R; Anton N; Anton H; Vandamme T; Vermot J; Smail D; Mély Y; Klymchenko AS Colloids Surf B Biointerfaces; 2017 Aug; 156():414-421. PubMed ID: 28551576 [TBL] [Abstract][Full Text] [Related]
9. Labeling the oily core of nanocapsules and lipid-core nanocapsules with a triglyceride conjugated to a fluorescent dye as a strategy to particle tracking in biological studies. Fiel LA; Contri RV; Bica JF; Figueiró F; Battastini AM; Guterres SS; Pohlmann AR Nanoscale Res Lett; 2014; 9(1):233. PubMed ID: 24936156 [TBL] [Abstract][Full Text] [Related]
10. Characterization of different functionalized lipidic nanocapsules as potential drug carriers. Sánchez-Moreno P; Ortega-Vinuesa JL; Martín-Rodríguez A; Boulaiz H; Marchal-Corrales JA; Peula-García JM Int J Mol Sci; 2012; 13(2):2405-2424. PubMed ID: 22408461 [TBL] [Abstract][Full Text] [Related]
11. Enhanced optical imaging properties of lipid nanocapsules as vehicles for fluorescent conjugated polymers. Modicano P; Neumann PR; Schüller M; Holthof J; Kyrilis FL; Hamdi F; Kastritis PL; Mäder K; Ann Dailey L Eur J Pharm Biopharm; 2020 Sep; 154():297-308. PubMed ID: 32707286 [TBL] [Abstract][Full Text] [Related]
12. Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models. Hirsjärvi S; Dufort S; Gravier J; Texier I; Yan Q; Bibette J; Sancey L; Josserand V; Passirani C; Benoit JP; Coll JL Nanomedicine; 2013 Apr; 9(3):375-87. PubMed ID: 22960195 [TBL] [Abstract][Full Text] [Related]
13. Lipid-Core Nanocapsules Act as a Drug Shuttle Through the Blood Brain Barrier and Reduce Glioblastoma After Intravenous or Oral Administration. Rodrigues SF; Fiel LA; Shimada AL; Pereira NR; Guterres SS; Pohlmann AR; Farsky SH J Biomed Nanotechnol; 2016 May; 12(5):986-1000. PubMed ID: 27305820 [TBL] [Abstract][Full Text] [Related]
14. An innovative hydrogel of gemcitabine-loaded lipid nanocapsules: when the drug is a key player of the nanomedicine structure. Moysan E; González-Fernández Y; Lautram N; Béjaud J; Bastiat G; Benoit JP Soft Matter; 2014 Mar; 10(11):1767-77. PubMed ID: 24652455 [TBL] [Abstract][Full Text] [Related]
15. Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers. Umerska A; Mouzouvi CR; Bigot A; Saulnier P Int J Pharm; 2015 Sep; 493(1-2):224-32. PubMed ID: 26183331 [TBL] [Abstract][Full Text] [Related]
16. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants. Umerska A; Cassisa V; Matougui N; Joly-Guillou ML; Eveillard M; Saulnier P Eur J Pharm Biopharm; 2016 Nov; 108():100-110. PubMed ID: 27597268 [TBL] [Abstract][Full Text] [Related]